{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:41:03Z","timestamp":1770889263276,"version":"3.50.1"},"publisher-location":"Cham","reference-count":105,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319901428","type":"print"},{"value":"9783319901435","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-90143-5_2","type":"book-chapter","created":{"date-parts":[[2018,6,8]],"date-time":"2018-06-08T06:04:16Z","timestamp":1528437856000},"page":"21-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Metallomics Applied to the\u00a0Study of Neurodegenerative and Mental Diseases"],"prefix":"10.1007","author":[{"given":"Alessandra","family":"Sussulini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel Ann","family":"Hauser-Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,9]]},"reference":[{"issue":"5","key":"2_CR1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/32.5.805","volume":"32","author":"DS Abdalla","year":"1986","unstructured":"Abdalla DS, Monteiro HP, Oliveira JA, Bechara E (1986) Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients. Clin Chem 32(5):805\u2013807","journal-title":"Clin Chem"},{"issue":"6","key":"2_CR2","volume":"5","author":"SSSJ Ahmed","year":"2010","unstructured":"Ahmed SSSJ, Santosh W (2010) Metallomic profiling and linkage map analysis of early Parkinson\u2019s disease: a new insight to aluminum marker for the possible diagnosis. PLoS One 5(6):e11252","journal-title":"PLoS One"},{"issue":"5","key":"2_CR3","first-page":"245","volume":"15","author":"G Arinola","year":"2010","unstructured":"Arinola G, Idonije B, Akinlade K, Ihenyen O (2010) Essential trace metals and heavy metals in newly diagnosed schizophrenic patients and those on anti-psychotic medication. J Res Med Sci 15(5):245\u2013249","journal-title":"J Res Med Sci"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainres.2009.11.085","volume":"1319","author":"N Arnal","year":"2010","unstructured":"Arnal N, Cristalli DO, de Alaniz MJT, Marra C (2010) Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Res 1319:118\u2013130","journal-title":"Brain Res"},{"issue":"10","key":"2_CR5","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1096\/fasebj.10.10.8751715","volume":"10","author":"M Aschner","year":"1996","unstructured":"Aschner M (1996) The functional significance of brain metallothioneins. FASEB J 10(10):1129\u20131136","journal-title":"FASEB J"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.23817","volume":"73","author":"S Ayton","year":"2013","unstructured":"Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, Adlard PA, Bush AI, Finkelstein DI (2013) Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol 73:554\u2013559","journal-title":"Ann Neurol"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-015-0055-2","volume":"10","author":"M Barbariga","year":"2015","unstructured":"Barbariga M, Curnis F, Andolfo A, Zanardi A, Lazzaro M, Conti A, Magnani G, Volont\u00e8 MA, Ferrari L, Comi G, Corti A, Alessio M (2015) Ceruloplasmin functional changes in Parkinson\u2019s disease-cerebrospinal fluid. Mol Neurodegener 10:59","journal-title":"Mol Neurodegener"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1039\/C4CS00138A","volume":"43","author":"KJ Barnham","year":"2014","unstructured":"Barnham KJ, Bush AI (2014) Biological metals and metal-targeting compounds in major neurodegenerative disorders. Chem Soc Rev 43:6727\u20136749","journal-title":"Chem Soc Rev"},{"key":"2_CR9","first-page":"231","volume":"3","author":"H Basun","year":"1991","unstructured":"Basun H, Forssell LG, Wetterberg L, Winblad B (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer\u2019s disease. J Neural Transm Park Dis Dement Sect 3:231\u2013258","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"12","key":"2_CR10","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s00415-009-0063-7","volume":"255","author":"KJ Bharucha","year":"2009","unstructured":"Bharucha KJ, Friedman JK, Vincent AS, Ross ED (2009) Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson\u2019s disease. J Neurol 255(12):1957\u20131962","journal-title":"J Neurol"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-2009-1177","volume":"18","author":"K Blennow","year":"2009","unstructured":"Blennow K, Zetterberg H (2009) Cerebrospinal fluid biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis 18:413\u2013417","journal-title":"J Alzheimers Dis"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000216841","volume":"27","author":"ES Blom","year":"2009","unstructured":"Blom ES, Giedraitis V, Zetterberg H, Fukumoto H, Blennow K, Hyman BT, Irizarry MC, Wahlund LO, Lannfelt L, Ingelsson M (2009) Rapid progression from mild cognitive impairment to Alzheimer\u2019s disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4\/epsilon4 genotype. Dement Geriatr Cogn Disord 27:458\u2013464","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2202-15-98","volume":"15","author":"SG Boaru","year":"2014","unstructured":"Boaru SG, Merle U, Uerlings R, Zimmermann A, Weiskirchen S, Matusch A, Stremmel W, Weiskirchen R (2014) Simultaneous monitoring of cerebral metal accumulation in an experimental model of Wilson\u2019s disease by laser ablation inductively coupled plasma mass spectrometry. BMC Neurosci 15:98\u2013111","journal-title":"BMC Neurosci"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.sab.2004.02.007","volume":"59","author":"B Bocca","year":"2004","unstructured":"Bocca B, Alimonti A, Petrucci F, Violante N, Sancesario G, Forte G, Senofonte O (2004) Quantification of trace elements by sector field inductively coupled plasma mass spectrometry in urine, serum, blood and cerebrospinal fluid of patients with Parkinson\u2019s disease. Spectrochim Acta B 59:559\u2013566","journal-title":"Spectrochim Acta B"},{"issue":"4","key":"2_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/00365510601095281","volume":"67","author":"BJ Bolann","year":"2007","unstructured":"Bolann BJ, Khazen-Rahil R, Henriksen H, Isrenn R, Ulvik RJ (2007) Evaluation of methods for trace-element determination with emphasis on their usability in the clinical routine laboratory. Scand J Clin Lab Invest 67(4):353\u2013366","journal-title":"Scand J Clin Lab Invest"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11064-008-9610-3","volume":"33","author":"MC Boll","year":"2008","unstructured":"Boll MC, Alcaraz-Zubeldia M, Montes S, Rios C (2008) Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem Res 33:1717\u20131723","journal-title":"Neurochem Res"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0304-3940(91)90711-2","volume":"129","author":"E Bonilla","year":"1991","unstructured":"Bonilla E, Estevez J, Suarez H, Morales LM, Chacin de Bonilla L, Villalobos R, D'Avila JO (1991) Serum ferritin deficiency in Huntington\u2019s disease patients. Neurosci Lett 129:22\u201324","journal-title":"Neurosci Lett"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/schbul\/20.2.387","volume":"20","author":"JSJ Brown","year":"1994","unstructured":"Brown JSJ (1994) Role of selenium and other trace elements in the geography of schizophrenia. Schizophr Bull 20:387\u2013398","journal-title":"Schizophr Bull"},{"issue":"1","key":"2_CR20","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S1353-8020(13)70025-7","volume":"20","author":"L Chahine","year":"2014","unstructured":"Chahine L, Stern M, Chen-Plotkin A (2014) Blood-based biomarkers for Parkinson\u2019s disease. Parkinsonism Relat Disord 20(1):S99\u2013S103","journal-title":"Parkinsonism Relat Disord"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/9812178","volume":"2016","author":"JS Crist\u00f3v\u00e3o","year":"2016","unstructured":"Crist\u00f3v\u00e3o JS, Santos R, Gomes CM (2016) Metals and neuronal metal binding proteins implicated in Alzheimer\u2019s disease. Oxidative Med Cell Longev 2016:1\u201313","journal-title":"Oxidative Med Cell Longev"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/ar300074t","volume":"45","author":"PJ Crouch","year":"2012","unstructured":"Crouch PJ, Barnham KJ (2012) Therapeutic redistribution of metal ions to treat Alzheimer\u2019s disease. Acc Chem Res 45:1604\u20131611","journal-title":"Acc Chem Res"},{"issue":"9","key":"2_CR23","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1177\/153537020623100919","volume":"231","author":"M Ebadi","year":"2006","unstructured":"Ebadi M, Sharma S (2006) Metallothioneins 1 and 2 attenuate peroxynitrite-induced oxidative stress in Parkinson disease. Exp Biol Med 231(9):1576\u20131583","journal-title":"Exp Biol Med"},{"key":"2_CR24","doi-asserted-by":"crossref","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, Curran MD, Court JA, Mann DM, Ikeda S, Cookson MR, Hardy J, Allsop D (2003) Alpha-synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma. FASEB J 17:1945\u20131947","DOI":"10.1096\/fj.03-0098fje"},{"issue":"1","key":"2_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/appi.psy.47.1.1","volume":"47","author":"O Fattal","year":"2006","unstructured":"Fattal O, Budur K, Vaughan AJ, Franco K (2006) Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 47(1):1\u20137","journal-title":"Psychosomatics"},{"issue":"2","key":"2_CR26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2036.2003.01813.x","volume":"19","author":"P Ferenci","year":"2004","unstructured":"Ferenci P (2004) Diagnosis and current therapy of Wilson\u2019s disease. Aliment Pharmacol Ther 19(2):157\u2013165","journal-title":"Aliment Pharmacol Ther"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00702-004-0124-0","volume":"111","author":"G Forte","year":"2004","unstructured":"Forte G, Bocca B, Senofonte O, Petrucci F, Brusa L, Stanzione P, Zannino S, Violante N, Alimonti A, Sancesario G (2004) Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson\u2019s disease. J Neural Transm 111:1031\u20131040","journal-title":"J Neural Transm"},{"issue":"2","key":"2_CR28","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5387\/fms.59.76","volume":"59","author":"T Fukushima","year":"2013","unstructured":"Fukushima T, Tan X, Luo Y, Wang P, Song J, Kanda H, Hayakawa T, Kumagai T, Kakamu T, Tsuji M, Hidaka T, Mori Y (2013) Heavy metals in blood and urine and its relation to depressive symptoms in Parkinson\u2019s disease patients. Fukushima J Med Sci 59(2):76\u201380","journal-title":"Fukushima J Med Sci"},{"issue":"3","key":"2_CR29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.pnpbp.2005.11.009","volume":"30","author":"CS Gama","year":"2006","unstructured":"Gama CS, Salvador M, Andreazza AC, Kapczinski F, Silva Belmonte-de-Abreu P (2006) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuro-Psychopharmacol Biol Psychiatry 30(3):512\u2013515","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1159\/000129365","volume":"25","author":"L Gerhardsson","year":"2008","unstructured":"Gerhardsson L, Lundh T, Minthon L, Londos E (2008) Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 25:508\u2013515","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2_CR31","first-page":"883","volume":"53","author":"S Goldfischer","year":"1968","unstructured":"Goldfischer S, Sternlieb I (1968) Changes in the distribution of hepatic copper in relation to the progression of Wilson\u2019s disease (hepatolenticular degeneration). Am J Pathol 53:883\u2013901","journal-title":"Am J Pathol"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1039\/C3MT00301A","volume":"6","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2014) Characterization of metal profiles in serum during the progression of Alzheimer\u2019s disease. Metallomics 6:292\u2013300","journal-title":"Metallomics"},{"issue":"1","key":"2_CR33","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jtemb.2010.10.015","volume":"25","author":"M Gonz\u00e1lez-Estecha","year":"2011","unstructured":"Gonz\u00e1lez-Estecha M, Trasobares EM, Tajima K, Cano S, Fern\u00e1ndez C, L\u00f3pez JL, Unzeta B, Arroyo M, Fuentenebro F (2011) Trace elements in bipolar disorder. J Trace Elem Med Biol 25(1):S78\u2013S83","journal-title":"J Trace Elem Med Biol"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2165\/00002512-200118090-00004","volume":"18","author":"B Halliwell","year":"2001","unstructured":"Halliwell B (2001) Role of free radicals in the neurodegenerative diseases. Drugs Aging 18:685\u2013716","journal-title":"Drugs Aging"},{"issue":"9","key":"2_CR35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tibs.2006.07.005","volume":"31","author":"B Halliwell","year":"2006","unstructured":"Halliwell B (2006) Phagocyte-derived reactive species: salvation or suicide? Trends Biochem Sci 31(9):509\u2013515","journal-title":"Trends Biochem Sci"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","volume":"4","author":"H Hampel","year":"2008","unstructured":"Hampel H, Burger K, Teipel S, Bokde A, Zetterberg H, Blennow K (2008) Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease. Alzheimers Dement 4:38\u201348","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2_CR37","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1042\/BST0380552","volume":"38","author":"SL Hands","year":"2010","unstructured":"Hands SL, Mason R, Sajjad MU, Giorgini F, Wyttenbach A (2010) Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington\u2019s disease. Biochem Soc Trans 38(2):552\u2013558","journal-title":"Biochem Soc Trans"},{"key":"2_CR38","doi-asserted-by":"crossref","unstructured":"Hare DJ, Kysenius K, Paul B, Knauer B, Hutchinson RW, O\u2019Connor C, \u2026 Doble PA (2017). Imaging Metals in Brain Tissue by Laser Ablation - Inductively Coupled Plasma - Mass Spectrometry (LA-ICP-MS). J Vis Exp 22(119) 55042. Advance online publication. http:\/\/doi.org\/10.3791\/55042","DOI":"10.3791\/55042"},{"issue":"9","key":"2_CR39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2174\/15672050113106660159","volume":"10","author":"J He","year":"2013","unstructured":"He J, Qiao JP, Zhu S, Xue M, Chen W, Wang X, Tempier A, Huang Q, Kong J, Li XM (2013) Serum \u03b2-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP\/PS1 double transgenic mouse model. Curr Alzheimer Res 10(9):979\u2013986","journal-title":"Curr Alzheimer Res"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ab.2005.08.024","volume":"346","author":"RW Hutchinson","year":"2005","unstructured":"Hutchinson RW, Cox AG, McLeod C, Marshall P, Harper A, Dawson EL, Howlett DR (2005) Imaging and spatial distribution of beta-amyloid peptide and metal ions in Alzheimer's plaques by laser ablation-inductively coupled plasma-mass spectrometry. Anal Biochem 346:225\u2013233","journal-title":"Anal Biochem"},{"issue":"2","key":"2_CR41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-510X(99)00192-6","volume":"170","author":"Y Ihara","year":"1999","unstructured":"Ihara Y, Chuda D, Kuroda S, Haybara T (1999) Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data. J Neurol Sci 170(2):90\u201395","journal-title":"J Neurol Sci"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/brain\/awq319","volume":"134","author":"L Jin","year":"2011","unstructured":"Jin L, Wang J, Zhao L, Jin H, Fei G, Zhang Y, Zeng M, Zhong C (2011) Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain 134:50\u201358","journal-title":"Brain"},{"issue":"2","key":"2_CR43","first-page":"77","volume":"22","author":"H-J Kim","year":"2013","unstructured":"Kim H-J (2013) Alpha-Synuclein expression in patients with Parkinson\u2019s disease: a Clinician\u2019s perspective. Exp Neurol 22(2):77\u201383","journal-title":"Exp Neurol"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.48.3.741","volume":"48","author":"T Kosaka","year":"1997","unstructured":"Kosaka T, Imagawa M, Seki K, Arai H, Sasaki H, Tsuji S, Asami-Odaka A, Fukushima T, Imai K, Iwatsubo T (1997) The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta42(43). Neurology 48:741\u2013745","journal-title":"Neurology"},{"issue":"7","key":"2_CR45","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.pnpbp.2008.07.001","volume":"32","author":"M Kunz","year":"2008","unstructured":"Kunz M, Gama CS, Andreazza AC, Salvador M, Cereser KM, Gomes FA, Belmonte-de-Abreu PS, Berk M, Kapczinski F (2008) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 32(7):1677\u20131681","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"2_CR46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5487\/TR.2012.28.2.093","volume":"28","author":"JY Lee","year":"2012","unstructured":"Lee JY, Kim JH, Choi DW, Lee DW, Park JH, Yoon HJ, Pyo HS, Kwon HJ, Park KS (2012) The association of heavy metal of blood and serum in the Alzheimer\u2019s diseases. Toxicol Res 28(2):93\u201398","journal-title":"Toxicol Res"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00702-005-0427-9","volume":"113","author":"PH Lee","year":"2006","unstructured":"Lee PH, Lee G, Park HJ, Bang OY, Joo IS, Huh K (2006) The plasma alpha-synuclein levels in patients with Parkinson\u2019s disease and multiple system atrophy. J Neural Transm 113:1435\u20131439","journal-title":"J Neural Transm"},{"issue":"4","key":"2_CR48","first-page":"241","volume":"22","author":"Y-H Lee","year":"2009","unstructured":"Lee Y-H, Wong DT (2009) Saliva: an emerging biofluid for early detection of diseases. Am J Dent 22(4):241\u2013248","journal-title":"Am J Dent"},{"key":"2_CR49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.expneurol.2006.12.006","volume":"204","author":"QX Li","year":"2007","unstructured":"Li QX, Mok SS, Laughton KM, McLean CA, Cappai R, Masters CL, Culvenor JG, Horne MK (2007) Plasma alpha-synuclein is decreased in subjects with Parkinson\u2019s disease. Exp Neurol 204:583\u2013588","journal-title":"Exp Neurol"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1471-4159.1995.65020710.x","volume":"65","author":"DA Loeffier","year":"1995","unstructured":"Loeffier DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA (1995) Transferrin and iron in normal, Alzheimer\u2019s disease, and Parkinson\u2019s disease brain regions. J Neurochem 65:710\u2013716","journal-title":"J Neurochem"},{"issue":"12","key":"2_CR51","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/bi061359o","volume":"46","author":"S Maeda","year":"2007","unstructured":"Maeda S, Sahara N, Saito Y, Murayama M, Yoshiike Y, Kim H, Miyasaka T, Murayama S, Ikai A, Takashima A (2007) Granular tau oligomers as intermediates of tau filaments. Biochemistry 46(12):3856\u20133861","journal-title":"Biochemistry"},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/toxics2020327","volume":"2","author":"M Manto","year":"2014","unstructured":"Manto M (2014) Abnormal copper homeostasis: mechanisms and roles in neurodegeneration. Toxics 2:27\u2013345","journal-title":"Toxics"},{"issue":"24","key":"2_CR53","doi-asserted-by":"crossref","first-page":"7634","DOI":"10.1073\/pnas.79.24.7634","volume":"79","author":"SL Marklund","year":"1982","unstructured":"Marklund SL (1982) Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A 79(24):7634\u20137638","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR54","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s11064-011-0535-x","volume":"36","author":"R Mart\u00ednez-Hern\u00e1ndez","year":"2011","unstructured":"Mart\u00ednez-Hern\u00e1ndez R, Montes S, Higuera-Calleja J, Yescas P, Boll MC, Diaz-Ruiz A, Rios C (2011) Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson\u2019s disease patients: a pilot study. Neurochem Res 36:2111\u20132115","journal-title":"Neurochem Res"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jasms.2009.09.022","volume":"21","author":"A Matusch","year":"2010","unstructured":"Matusch A, Depboylu C, Palm C, Wu B, H\u00f6glinger GU, Sch\u00e4fer KH, Becker JS (2010) Cerebral bioimaging of Cu, Fe, Zn, and Mn in the MPTP mouse model of Parkinson\u2019s disease using laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS). J Am Soc Mass Spectrom 21:161\u2013171","journal-title":"J Am Soc Mass Spectrom"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1021\/ac203112c","volume":"84","author":"A Matusch","year":"2012","unstructured":"Matusch A, Fenn LS, Depboylu C, Klietz M, Strohmer S, McLean JA, Becker JS (2012) Combined elemental and biomolecular mass spectrometry imaging (MSI) for probing the inventory of tissue at a micrometer scale. Anal Chem 84:3170\u20133178","journal-title":"Anal Chem"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","volume":"57","author":"PD Mehta","year":"2000","unstructured":"Mehta PD, Pirttila T, Mehta SP, Sersen EA, Aisen PS, Wisniewski HM (2000) Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch Neurol 57:100\u2013105","journal-title":"Arch Neurol"},{"issue":"4","key":"2_CR58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10048-011-0294-5","volume":"12","author":"GJ Michael","year":"2011","unstructured":"Michael GJ, Esmailzadeh S, Moran LB, Christian L, Pearce RKB, Graeber MB (2011) Up-regulation of metallothionein gene expression in Parkinsonian astrocytes. Neurogenetics 12(4):295\u2013305","journal-title":"Neurogenetics"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s007020050071","volume":"105","author":"J Molina","year":"1998","unstructured":"Molina J, Jim\u00e9nez-Jim\u00e9nez F, Aguilar M, Meseguer I, Mateos-Vega CJ, Gonz\u00e1lez-Mu\u00f1oz MJ, de Bustos F, Porta J, Ort\u00ed-Pareja M, Zurdo M, Barrios E, Mart\u00ednez-Para MC (1998) Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm 105:479\u2013488","journal-title":"J Neural Transm"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF02943258","volume":"163","author":"PJ Morrison","year":"1994","unstructured":"Morrison PJ, Nevin NC (1994) Serum iron, total iron binding capacity and ferritin in early Huntington disease patients. Ir J Med Sci 163:236\u2013237","journal-title":"Ir J Med Sci"},{"issue":"1","key":"2_CR61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0920-9964(95)00048-8","volume":"19","author":"S Mukerjee","year":"1996","unstructured":"Mukerjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H (1996) Impaired antioxidant defense at the onset of psychosis. Schizophr Res 19(1):19\u201326","journal-title":"Schizophr Res"},{"issue":"3","key":"2_CR62","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0168-8278(05)80667-1","volume":"16","author":"TP Mulder","year":"1992","unstructured":"Mulder TP, Janssens AR, Verspaget HW, van Hattum J, Lamers CB (1992) Metallothionein concentration in the liver of patients with Wilson\u2019s disease, primary biliary cirrhosis, and liver metastasis of colorectal cancer. J Hepatol 16(3):346\u2013350","journal-title":"J Hepatol"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jnc.12739","volume":"130","author":"M Muller","year":"2014","unstructured":"Muller M, Leavitt BR (2014) Iron dysregulation in Huntington\u2019s disease. J Neurochem 130:328\u2013350","journal-title":"J Neurochem"},{"issue":"1","key":"2_CR64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H (2010) Alzheimer\u2019s disease and the \u03b2-amyloid peptide. J Alzheimers Dis 19(1):311\u2013327","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"2_CR65","first-page":"397","volume":"57","author":"NO Nartey","year":"1987","unstructured":"Nartey NO, Frei JV, Cherian MG (1987) Hepatic copper and metallothionein distribution in Wilson\u2019s disease (hepatolenticular degeneration). Lab Investig 57(4):397\u2013401","journal-title":"Lab Investig"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4236\/wjns.2014.45051","volume":"4","author":"R Nawaz","year":"2014","unstructured":"Nawaz R, Zahir E, Siddiqui S, Usmani A, Shad KF (2014) The role of trace metals and environmental factors in the onset and progression of schizophrenia in Pakistani population. World J Neurosci 4:450\u2013460","journal-title":"World J Neurosci"},{"issue":"2","key":"2_CR67","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1203\/00006450-199502000-00016","volume":"37","author":"H Ogihara","year":"1995","unstructured":"Ogihara H, Ogihara T, Miki M, Yasuda H, Mino M (1995) Plasma copper and antioxidant status in Wilson\u2019s disease. Pediatr Res 37(2):219\u2013226","journal-title":"Pediatr Res"},{"key":"2_CR68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1192\/bjp.127.2.119","volume":"127","author":"DA Olatunbosun","year":"1975","unstructured":"Olatunbosun DA, Akindele MO, Adadevoh BK, Asuni T (1975) Serum copper in schizophrenia in Nigerians. Br J Psychiatry 127:191\u2013121","journal-title":"Br J Psychiatry"},{"issue":"8","key":"2_CR69","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/1947-2714.139283","volume":"6","author":"OE Orisakwe","year":"2014","unstructured":"Orisakwe OE (2014) The role of lead and cadmium in psychiatry. N Am J Med Sci 6(8):370\u2013376","journal-title":"N Am J Med Sci"},{"issue":"1","key":"2_CR70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/appy.12077","volume":"6","author":"JH Park","year":"2014","unstructured":"Park JH, Lee DW, Park KS (2014) Elevated serum copper and ceruloplasmin levels in Alzheimer\u2019s disease. Asia-Pacific Psychiatry 6(1):38\u201345","journal-title":"Asia-Pacific Psychiatry"},{"key":"2_CR71","first-page":"914","volume":"13","author":"N Pomara","year":"2005","unstructured":"Pomara N, Willoughby LM, Sidtis JJ, Mehta PD (2005) Selective reductions in plasma Abeta 1-42 in healthy elderly subjects during longitudinal follow-up: a preliminary report. Am J Geriatr Psychiatr 13:914\u2013917","journal-title":"Am J Geriatr Psychiatr"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/00207454.2016.1174118","volume":"127","author":"A Prakash","year":"2017","unstructured":"Prakash A, Dhaliwal GK, Kumar P, Majeed AB (2017) Brain biometals and Alzheimer\u2019s disease - boon or bane? Int J Neurosci 127:99\u2013108","journal-title":"Int J Neurosci"},{"issue":"2","key":"2_CR73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","volume":"121","author":"PK Ranjekar","year":"2003","unstructured":"Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP (2003) Decreased antioxidant enzymes and membrane essential poly- unsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121(2):109\u2013122","journal-title":"Psychiatry Res"},{"issue":"12","key":"2_CR74","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1073\/pnas.0407881102","volume":"102","author":"RM Rasia","year":"2005","unstructured":"Rasia RM, Bertoncini CW, Marsh D, Hpyser W, Cherny D, Zweckstetter M, Griesinger C, Jovin TM, Fern\u00e1ndez CO (2005) Structural characterization of copper(II) binding to \u03b1-synuclein: insights into the bioinorganic chemistry of Parkinson's disease. Proc Natl Acad Sci U S A 102(12):4294\u20134299","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"2_CR75","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.4254\/wjh.v7.i29.2859","volume":"7","author":"KI Rodriguez-Castro","year":"2015","unstructured":"Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC (2015) Wilson\u2019s disease: a review of what we have learned. World J Hepatol 7(29):2859\u20132870","journal-title":"World J Hepatol"},{"key":"2_CR76","first-page":"893","volume":"28","author":"M Rohani","year":"2013","unstructured":"Rohani M, Jalali N, Khademolhosseini M, Miri S, Shahidi GA, Ghourchian S (2013) Serum ceruloplasmin and ferritin levels in patients with Parkinson\u2019s disease. Mov Disord 28:893","journal-title":"Mov Disord"},{"key":"2_CR77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/gps.2353","volume":"25","author":"K Samgard","year":"2010","unstructured":"Samgard K, Zetterberg H, Blennow K, Hansson O, Minthon L, Londos E (2010) Cerebrospinal fluid total tau as a marker of Alzheimer\u2019s disease intensity. Int J Geriatr Psychiatry 25:403\u2013410","journal-title":"Int J Geriatr Psychiatry"},{"key":"2_CR78","doi-asserted-by":"crossref","DOI":"10.1038\/srep35097","volume":"6","author":"J Sanyal","year":"2016","unstructured":"Sanyal J, Shiek SSJ, Ng HKT, Naiya T, Ghosh E, Banerjee TK, Lakshmi J, Guha G, Rao VR (2016) Metallomic biomarkers in cerebrospinal fluid and serum in patients with Parkinson\u2019s disease in Indian population. Sci Rep 6:35097","journal-title":"Sci Rep"},{"key":"2_CR79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jns.2007.01.033","volume":"257","author":"K Sas","year":"2007","unstructured":"Sas K, Robotka H, Toldi J, V\u00e9csei L (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257:221\u2013239","journal-title":"J Neurol Sci"},{"issue":"1","key":"2_CR80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/15622970510029993","volume":"7","author":"HA Savas","year":"2006","unstructured":"Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, Selek S, Tutkun H, Zoroglu SS, Akyol O (2006) Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 7(1):51\u201355","journal-title":"World J Biol Psychiatry"},{"key":"2_CR81","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird T, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad L, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt SD, Younkin S (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med 2:864\u2013870","journal-title":"Nat Med"},{"key":"2_CR82","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1755-5949.2009.00104.x","volume":"15","author":"P Schneider","year":"2009","unstructured":"Schneider P, Hampel H, Buerger K (2009) Biological marker candidates of Alzheimer\u2019s disease in blood, plasma, and serum. CNS Neurosci Ther 15:358\u2013374","journal-title":"CNS Neurosci Ther"},{"key":"2_CR83","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1073\/pnas.0805902105","volume":"105","author":"N Schupf","year":"2008","unstructured":"Schupf N, Tang MX, Fukuyama H, Manly J, Andrews H, Mehta P, Ravetch J, Mayeux R (2008) Peripheral Abeta subspecies as risk biomarkers of Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 105:14052\u201314057","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20133","key":"2_CR84","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2007.08.006","volume":"107","author":"S Selek","year":"2008","unstructured":"Selek S, Savas HA, Gergerlioglu HS, Bulbul F, Uz E, Yumru M (2008) The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 107(1\u20133):89\u201394","journal-title":"J Affect Disord"},{"issue":"1","key":"2_CR85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4038\/sljpsyc.v5i1.7076","volume":"5","author":"SK Sharma","year":"2013","unstructured":"Sharma SK, Sood S, Sharma A, Gupta ID (2013) Estimation of serum zinc and copper levels patients with schizophrenia: a preliminary study. Sri Lanka J Psychiatry 5(1):14\u201317","journal-title":"Sri Lanka J Psychiatry"},{"issue":"7","key":"2_CR86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159099","volume":"11","author":"S Shekhar","year":"2016","unstructured":"Shekhar S, Kumar R, Rai N, Kumar V, Singh K, Upadhyay AD, Tripathi M, Dwivedi S, Dey AB, Dey S (2016) Estimation of tau and phosphorylated Tau181 in serum of Alzheimer\u2019s disease and mild cognitive impairment patients. PLoS One 11(7):e0159099","journal-title":"PLoS One"},{"issue":"5646","key":"2_CR87","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) \u03b1-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302(5646):841","journal-title":"Science"},{"key":"2_CR88","doi-asserted-by":"crossref","first-page":"469","DOI":"10.12740\/PP\/OnlineFirst\/65250","volume":"51","author":"M Siwek","year":"2017","unstructured":"Siwek M, Stycz\u00e9n K, Sowa-Ku\u0107ma M, Dudek D, Reczy\u0144ski W, Szewczyk B, Misztak P, Opoka W, Top\u00f3r-M\u0105dry R, Nowak G, Rybakowski JK (2017) The serum concentration of copper in bipolar disorder. Psychiatr Pol 51:469\u2013481","journal-title":"Psychiatr Pol"},{"key":"2_CR89","doi-asserted-by":"crossref","DOI":"10.1038\/srep12166","volume":"5","author":"AL Southwell","year":"2015","unstructured":"Southwell AL, Smith EP, Davis TR, Caron NS, Villanueva EB, Xie Y, Collins JA, Ye ML, Sturrock A, Leavitt BR, Schrum AG, Hayden MR (2015) Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression. Sci Rep 5:12166","journal-title":"Sci Rep"},{"issue":"8","key":"2_CR90","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.59.8.1153","volume":"59","author":"R Squitti","year":"2002","unstructured":"Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Vernieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossini PM (2002) Elevation of serum copper levels in Alzheimer\u2019s disease. Neurology 59(8):1153\u20131161","journal-title":"Neurology"},{"key":"2_CR91","first-page":"46","volume":"2","author":"R Squitti","year":"2013","unstructured":"Squitti R, Polimanti R (2013) Copper phenotype in Alzheimer\u2019s disease: dissecting the pathway. Am J Neurodegener Dis 2:46\u201356","journal-title":"Am J Neurodegener Dis"},{"key":"2_CR92","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2353\/ajpath.2010.090355","volume":"176","author":"P Steinacker","year":"2010","unstructured":"Steinacker P, Hawlik A, Lehnert S, Jahn O, Meier S, G\u00f6rz E, Braunstein KE, Krzovska M, Schwalenst\u00f6ker B, Jesse S, Pr\u00f6pper C, B\u00f6ckers T, Ludolph A, Otto M (2010) Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis. Am J Pathol 176:1409\u20131420","journal-title":"Am J Pathol"},{"issue":"3","key":"2_CR93","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0584-8547(95)01425-X","volume":"51","author":"KS Subramanian","year":"1996","unstructured":"Subramanian KS (1996) Determination of metals in biofluids and tissues: sample preparation methods for atomic spectroscopic techniques. Spectrochim Acta B At Spectrosc 51(3):291\u2013319","journal-title":"Spectrochim Acta B At Spectrosc"},{"key":"2_CR94","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mas.21481","volume":"36","author":"A Sussulini","year":"2017","unstructured":"Sussulini A, Becker JS, Becker JS (2017) Laser ablation ICP-MS: application in biomedical research. Mass Spectrom Rev 36:47\u201357","journal-title":"Mass Spectrom Rev"},{"issue":"13","key":"2_CR95","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1021\/ac101063t","volume":"82","author":"A Sussulini","year":"2010","unstructured":"Sussulini A, Kratzin H, Jahn O, Banzato CE, Arruda MA, Becker JS (2010) Metallomics studies of human blood serum from treated bipolar disorder patients. Anal Chem 82(13):5859\u20135864","journal-title":"Anal Chem"},{"key":"2_CR96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3233\/BSI-2012-0011","volume":"1","author":"A Sussulini","year":"2012","unstructured":"Sussulini A, Matusch A, Klietz M, Bauer A, Depboylu C, Becker JS (2012) Quantitative imaging of Cu, Fe, Mn and Zn in the L-DOPA-treated unilateral 6-hydroxydopamine Parkinson\u2019s disease mouse model by LA-ICP-MS. Biomed Spectrosc Imaging 1:125\u2013136","journal-title":"Biomed Spectrosc Imaging"},{"issue":"5","key":"2_CR97","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-0773.1999.tb02015.x","volume":"85","author":"G T\u00f3rsd\u00f3ttir","year":"1999","unstructured":"T\u00f3rsd\u00f3ttir G, Kristinsson J, Sveinbj\u00f6rnsd\u00f3ttir S, Snaedal J, J\u00f3hannesson T (1999) Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease. Pharmacol Toxicol 85(5):239\u2013243","journal-title":"Pharmacol Toxicol"},{"issue":"7","key":"2_CR98","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1176\/ajp.136.7.937","volume":"136","author":"SP Tyrer","year":"1979","unstructured":"Tyrer SP, Delves HT, Weller MP (1979) CSF copper in schizophrenia. Am J Psychiatry 136(7):937\u2013939","journal-title":"Am J Psychiatry"},{"key":"2_CR99","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","volume":"5","author":"M Oijen van","year":"2006","unstructured":"van Oijen M, Hofman A, Soares HD, Koudstaal PJ, Breteler MM (2006) Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study. Lancet Neurol 5:655\u2013660","journal-title":"Lancet Neurol"},{"key":"2_CR100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3233\/JAD-2012-120244","volume":"30","author":"M Ventriglia","year":"2012","unstructured":"Ventriglia M, Bucossi S, Panetta V, Squitti R (2012) Copper in Alzheimer\u2019s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis 30:981\u2013984","journal-title":"J Alzheimers Dis"},{"key":"2_CR101","first-page":"282","volume":"18","author":"O Virit","year":"2008","unstructured":"Virit O, Altindag A, Selek S, Yumru M, Bulut M, Erel O, Savas HA, Herken H (2008) Increased plasma ceruloplasmin levels in schizophrenia. Klinik Psikofarmakoloji B\u00fclteni 18:282\u2013287","journal-title":"Klinik Psikofarmakoloji B\u00fclteni"},{"key":"2_CR102","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/mrm.25420","volume":"74","author":"C Wisnieff","year":"2015","unstructured":"Wisnieff C, Ramanan S, Olesik J, Gauthier S, Wang Y, Pitt D (2015) Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: interpreting positive susceptibility and the presence of iron. Magn Reson Med 74:564\u2013570","journal-title":"Magn Reson Med"},{"key":"2_CR103","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2013.02.015","volume":"46","author":"JQ Wu","year":"2013","unstructured":"Wu JQ, Kosten TR, Zhang XY (2013) Free radicals antioxidant defense systems, and schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 46:200\u2013206","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"2_CR104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/BTER:98:2:109","volume":"98","author":"Medaim Yanik","year":"2004","unstructured":"Yanik M, Kocyigit A, Tutkun H, Vural H, Herken H (2004) Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia. Biol Trace Elem Res 98:109\u2013117","journal-title":"Biological Trace Element Research"},{"issue":"2","key":"2_CR105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/alzrt163","volume":"5","author":"H Zetterberg","year":"2013","unstructured":"Zetterberg H, Wilson D, Andreasson U, Minthon L, Blennow K, Randall J, Hansson O (2013) Plasma tau levels in Alzheimer\u2019s disease. Alzheimers Res Ther 5(2):9","journal-title":"Alzheimers Res Ther"}],"container-title":["Advances in Experimental Medicine and Biology","Metallomics"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-90143-5_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T06:56:49Z","timestamp":1604386609000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-90143-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319901428","9783319901435"],"references-count":105,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-90143-5_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}